RESPOND seeks to increase the use of high-quality family planning services by ensuring a wide range of contraceptive options, including the informed and voluntary use of long-acting and permanent contraception. Long-acting methods include the intrauterine device and hormonal implants; permanent methods include male and female sterilization. FHI 360 serves as a research partner for the project, which is led by EngenderHealth. In Tanzania, FHI 360 collected data on the cost of providing mobile family planning outreach services. In Albania and Azerbaijan, FHI 360 researched factors affecting the low use of modern contraceptives.